An observational study in Scoliosis Patients, sponsored by Joseph D. Tobias. Enrolling by invitation at 1 site in United States. Open to participants aged 10 Years to 21 Years. Per ClinicalTrials.gov, last updated 2025-10-27.
Sponsored by Joseph D. Tobias · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 153 studies in Scoliosis with a site in United States — 42 open to participants now, 51 under way, 2 of them phase 3. Scoliosis · United States.
Among the 153 studies in Scoliosis with a site in United States, this one is the 39th largest by planned enrollment of the 62 observational ones that give a count, is one of 9 that started in 2025, is one of 62 observational ones, reaches primary completion later than 14 of the 50 other live ones, and was the 145th registered.
660 studies on the registry are indexed under Scoliosis; 185 are open to participants now.
Browse Scoliosis studies →42 of the 153 studies in Scoliosis with a site in United States are open now. Recruiting first, the newest first:
Children's Hospital Medical Center, Cincinnati · Sites in United States
Ages 14–26
Thinks Works, PBC · Sites in United States
Ages 9–16
Columbia University · Sites in United States
Ages 10–19
Senthil Sadhasivam · Sites in United States
Ages 10–18
Children's Hospital Los Angeles · Sites in United States
Ages 8–18
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 117 Scoliosis studies recruiting now, 23 (20%) set no upper age limit and 88 (75%) stop at 75 or younger; 98 take children under 18; 14 take healthy volunteers.
This study: 10 Years to 21 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
153 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 6 · Phase 3 6 · Phase 4 15
First in 1998; this study’s year is marked. 9 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 50 is below the median of 84 across 256 observational studies indexed under Scoliosis.
Median enrollment 58 across the 91 interventional studies, 100 across the 62 observational. Of the 85 that completed or were terminated, 35 (41%) have results posted.
This tab as a report to print or save as PDF → With an account.
24 of 153 have an industry lead sponsor. The 10 most frequent:
Joseph D. Tobias is the lead sponsor of 28 studies on the registry; 4 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 6 (100%) have results posted.
Joseph D. Tobias has 2 studies filed under Scoliosis — fewer than ten, so there is no comparison to draw.
20 of the studies in Scoliosis with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07217873Phase 3Columbia UniversityIntraVenous Iron in Kids With Iron Deficiency and Scoliosis Study | 2027-08-31 |
| NCT00738439International Spine Study Group FoundationProspective, Multi-Center Adult Spinal Deformity Outcomes Database Registry | 2026-12 |
| NCT06910228Joseph D. TobiasChanges in Cerebral Oxygenation Related to Intraoperative Position Changes | 2026-12 |
| NCT06365892University of California, San FranciscoOpen-label Placebo (COLP) for Pain in Adolescent Idiopathic Scoliosis (AIS) Surgery+Surgical Treatment of Idiopathic Scoliosis | 2026-12 |
| NCT03017755Mayo ClinicScoliosis Survey to Development Treatment Decision Tool | 2026-12-01 |
Add all 20 to your calendar (.ics) → With an account.
Among the 153 studies in Scoliosis with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This is a prospective, observational study. This study will assess the effect of temporary changes in body position (supine, head of bed elevated 30 degrees, head of bed elevated 60 degrees) in anesthetized patients. Tissue oxygenation will be assessed non-invasively using near infrared spectroscopy (NIRS) by a device that is used in our operating rooms and the ICU setting to assess cerebral and tissue oxygenation.
Patients having surgery at Nationwide Children's Hospital.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
A non-invasive technique that uses light to assess brain function and tissue oxygenation.
Change in cerebral oxygenation at 30 degrees
Moving the head of the bed to 30 degrees and comparing cerebral oxygen levels to levels when patient was lying flat.
Time frame: 5-10 minutes after start of study
Change in cerebral oxygenation at 60 degrees
Moving the head of the bed to 60 degrees and comparing cerebral oxygen levels to levels when patient was lying flat.
Time frame: 10-15 minutes after start of study
Plan to share: No
No publications or documents are linked to this record.
Started Sep 2025 (actual). Primary completion is estimated for Dec 2026, 15 months after the start.
Of 94 non-industry observational studies under Scoliosis, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 99. This study's planned 15 months is below that.
Counting every sponsor, half of 106 studies reached it within 36 months; a quarter within 9 and three quarters within 92.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Joseph D. Tobias